Johnson & Johnson has joined the ranks of funders supporting the California Institute for Quantitative Biosciences Bridging-the-Gap Awards by providing two grants for research on an implantable pancreas for type 1 diabetes patients and on orally bioavailable macrocycles that inhibit protein-protein interactions.